SM
Satakarni Makkapati
About Satakarni Makkapati
Data last updated:
Satakarni Makkapati has 5 years in corporate governance. Holds Director and Ceo roles. Currently with 7 companies, including Aurobindo Pharma Ltd and Engenra Biologics Private Limited. Formerly with 1 company, such as Tergene Biotech Limited. Engaged in General Business, Technology. Contributes to corporate operations. The 6 current companies with reported revenue have a combined latest revenue of ₹41,002 Cr; the largest is Aurobindo Pharma Ltd at ₹34,145 Cr (FY 2026).
Current companies
| Company | Designation | Appointment | Founded | Revenue | Status |
|---|---|---|---|---|---|
 Aurobindo Pharma Ltd L24239TG1986PLC015190 | Director | 09 Nov 2023 | 1986 | ₹34,145 Cr (FY 2026) | Active |
| Apitoria Pharma Private Limited U24298TG2017PTC121342 | Director | 23 May 2023 | 2017 | ₹6,812 Cr (FY 2025) | Active |
| Auro Peptides Limited U24232TG2012PLC078350 | Director | 02 Nov 2021 | 2012 | ₹23.52 Cr (FY 2025) | Active |
 Auro Vaccines Private Limited U24297TG2021PTC156684 | Director | 08 Nov 2021 | 2021 | ₹11.82 Cr (FY 2025) | Active |
| Curateq Biologics Private Limited U24110TG2020PTC140190 | Ceo | 09 Aug 2021 | 2020 | ₹9.49 Cr (FY 2025) | Active |
| Theranym Biologics Private Limited U24230TG2022PTC166946 | Director | 22 Sep 2022 | 2022 | ₹3,000 (FY 2025) | Active |
| Engenra Biologics Private Limited U21000TS2026PTC212027 | Director | 24 Feb 2026 | 2026 | – | Active |
Previous companies
| Company | Designation | Appointment | Founded | Revenue | Status |
|---|---|---|---|---|---|
 Tergene Biotech Limited U24230TG2008PLC113178 | Additional Director | 27 Oct 2021 | 2008 | ₹8.9 Lakh (FY 2025) | Active |
Explore Director's current and past company associations Uncover their professional journey today!
Directorship timeline
Open interactive timeline →Shareholding and investment profile for Satakarni Makkapati
Company-level share counts, filed values, and quarterly changes require authenticated premium access.
- Company-level holdings
- Filed share counts
- Reported values
- Quarterly changes
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Satakarni Makkapati
Satakarni Makkapati has 5 years in corporate governance. Holds Director and Ceo roles. Currently with 7 companies, including Aurobindo Pharma Ltd and Engenra Biologics Private Limited. Formerly with 1 company, such as Tergene Biotech Limited. Engaged in General Business, Technology. Contributes to corporate operations. The 6 current companies with reported revenue have a combined latest revenue of ₹41,002 Cr; the largest is Aurobindo Pharma Ltd at ₹34,145 Cr (FY 2026).
Satakarni Makkapati is associated with 7 companies as Director and Ceo, including Aurobindo Pharma Ltd (₹34,145 Cr), Apitoria Pharma Private Limited (₹6,812 Cr), Auro Peptides Limited (₹23.52 Cr).
Satakarni Makkapati has expertise in General Business, Technology.
Satakarni Makkapati has 5 years in corporate governance.
By reported revenue, the largest current company of Satakarni Makkapati is Aurobindo Pharma Ltd, with revenue of ₹34,145 Cr (FY 2026).
The 6 current companies of Satakarni Makkapati that report revenue have a combined latest revenue of ₹41,002 Cr.
Satakarni Makkapati currently holds positions at 7 companies; the 5 largest by reported revenue are Aurobindo Pharma Ltd (₹34,145 Cr), Apitoria Pharma Private Limited (₹6,812 Cr), Auro Peptides Limited (₹23.52 Cr), Auro Vaccines Private Limited (₹11.82 Cr), Curateq Biologics Private Limited (₹9.49 Cr).